VABYSMO 6 mg/.05mL
Faricimab · INJECTION, SOLUTION · Genentech, Inc.
No Recall History
Plain English
VABYSMO is a injection, solution containing faricimab at 6 mg/.05mL, taken intravitreal. Manufactured by Genentech, Inc..
Key Facts
- Brand Name
- VABYSMO
- Generic Name
- Faricimab
- NDC Code (Product)
50242-096- Manufacturer
- Genentech, Inc.
- Strength
- 6 mg/.05mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- INTRAVITREAL
- Marketing Status
- Application #
- BLA761235
- Marketing Start
- 01/28/2022
Recall History
No Recall HistoryFrequently Asked Questions
What is VABYSMO used for?
VABYSMO contains Faricimab. It is a injection, solution taken intravitreal. Consult your doctor for specific uses.
Is VABYSMO a controlled substance?
VABYSMO is not classified as a controlled substance by the DEA.
What is the generic name for VABYSMO?
The generic name for VABYSMO is Faricimab. There are no other listed brand versions of Faricimab.
What is the NDC code for VABYSMO 6 mg/.05mL?
The NDC (National Drug Code) for VABYSMO 6 mg/.05mL is 50242-096, listed by Genentech, Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)